SC
PALI icon

Steven Cohen’s Palisade Bio PALI Stock Holding History

Steven Cohen’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Buy
5,253,403
+4,841,631
+1,176% +$9.53M 0.01% 1226
2026
Q1 		$721K Sell
411,772
-10,083,480
-96% -$18.3M ﹤0.01% 2948
2025
Q4 		$24.7M Buy
+10,495,252
New +$20.2M 0.03% 766

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Steven Cohen's PALI Position: Q2 2026 in Review

Steven Cohen increased its Palisade Bio (PALI) stake by 1,176% in Q2 2026, buying an estimated $9.53M and bringing the position to 5,253,403 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #1226.

Steven Cohen first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. The position peaked at $24.7M in Q4 2025. 123 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Steven Cohen held 5,253,403 shares of Palisade Bio worth $11M as of Q2 2026.
  • Steven Cohen bought 4,841,631 Palisade Bio shares in Q2 2026, an estimated $9.53M.
  • Palisade Bio made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1226 holding.
  • Steven Cohen first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
  • Steven Cohen's Palisade Bio position peaked at $24.7M in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.